Two Evonik technologies win the 2016 China Personal Care & Cosmetics Innovation Award
After votes cast by an expert judging panel and also online voting, two leading innovative technologies from Evonik were chosen from a total of 79 submitted entrants from 56 companies, winning the 2016 China Personal Care & Cosmetics Innovation Award.
The Evonik emulsifier combination system - TEGO® Care CG 90 and TEGOSOFT® PC 31 - won the innovation award in the category of "functional ingredient – emulsifying." This formula system has been well accepted by consumers, especially those who prefer low viscosity products. It provides a light, non-sticky skin feeling, is easier to spread during application and is quickly absorbed. Compared to other conventional systems, sprayability is excellent. The emulsifier combination is PEG-free and fully based on renewable sources. It is especially suitable for low viscosity systems such as body or facial sprays, sunscreen formula, or serum and mask systems.
Evonik’s high-oil-containing structured surfactant technology won the innovation award in the category of "functional ingredient – others." TEGO® Sulfosuccinate DO 75, a hydrophobic surfactant, is a key building block in formulating high-oil-containing (15%-50%) structured surfactant systems containing multilamellar vesicles. The formulations obtained provide a creamy texture, good foaming properties, excellent skin hydration, and improved skin smoothness. The versatile formulation concept can be applied for the development of body washes, cleansing conditioners, facial washes, liquid hand soaps, or makeup removers.
The 2016 China Personal Care & Cosmetics Innovation Award is China's premium technology innovation award, and is co-organized by Reed Sinopharm Exhibitions and its trade show - The Personal Care and Homecare Ingredients Show 2016 (PCHi 2016) - China Personal Care and Cosmetic Industry Alliance and Ringier Trade Media, HAPPI China magazine.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around
€4.9 billion in 2015.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.